Merck's Enflonsia vaccine for respiratory syncytial virus won approval from the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices.

Kennedy’s controversial panel overhaul met its first test. The result? A major win for public health ahead of RSV season. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., who has ...

The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...

The votes in favor of Merck's shot are a sigh of relief after Kennedy gutted the panel and tapped replacements, some of whom are well-known vaccine critics.

Merck’s RSV preventive antibody for infants is approved by FDA. A recommendation from the Advisory Committee on Immunization Practices must be approved by the director of the CDC or the health ...

Robert F. Kennedy Jr.’s vaccine advisory committee recommended Merck & Co.’s shot to prevent newborns from getting RSV, alleviating some concerns that the new Department of Health and Human ...

A newly configured federal vaccine panel's June 25 action is expected to improve options to protect infants from potentially deadly RSV.

Advisers endorse Merck RSV antibody The advisers also voted 5-2 on Thursday to recommend the use of a new shot that can protect babies from respiratory syncytial virus, ...

Dr. Cody Meissner, who voted to recommend the Merck shot, said June 25 that the result data from Beyfortus in the past RSV season was an “astonishing accomplishment.” In case you missed: RFK ...

CDC advisers recommend Merck's Enflonsia to protect babies from RSV, addressing the leading cause of infant hospitalization. Skip to content. NOWCAST KETV NewsWatch 7 at 6:00.

CDC advisers recommend Merck's Enflonsia to protect babies from RSV, addressing the leading cause of infant hospitalization. Skip to content. NOWCAST WYFF News 4 at Noon.